404 related articles for article (PubMed ID: 18940256)
1. Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy.
del Pozo-Rodríguez A; Solinís MA; Gascón AR; Pedraz JL
Eur J Pharm Biopharm; 2009 Feb; 71(2):181-9. PubMed ID: 18940256
[TBL] [Abstract][Full Text] [Related]
2. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles.
Howard MD; Lu X; Jay M; Dziubla TD
Drug Dev Ind Pharm; 2012 Oct; 38(10):1270-9. PubMed ID: 22235767
[TBL] [Abstract][Full Text] [Related]
3. Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.
Mohammed-Saeid W; Michel D; El-Aneed A; Verrall RE; Low NH; Badea I
J Pharm Pharm Sci; 2012; 15(4):548-67. PubMed ID: 23106958
[TBL] [Abstract][Full Text] [Related]
4. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization.
Heiati H; Tawashi R; Phillips NC
J Microencapsul; 1998; 15(2):173-84. PubMed ID: 9532523
[TBL] [Abstract][Full Text] [Related]
5. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.
Vighi E; Ruozi B; Montanari M; Battini R; Leo E
Int J Pharm; 2010 Apr; 389(1-2):254-61. PubMed ID: 20100555
[TBL] [Abstract][Full Text] [Related]
6. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.
Choi SH; Jin SE; Lee MK; Lim SJ; Park JS; Kim BG; Ahn WS; Kim CK
Eur J Pharm Biopharm; 2008 Mar; 68(3):545-54. PubMed ID: 17881199
[TBL] [Abstract][Full Text] [Related]
7. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology.
Teeranachaideekul V; Junyaprasert VB; Souto EB; Müller RH
Int J Pharm; 2008 Apr; 354(1-2):227-34. PubMed ID: 18242898
[TBL] [Abstract][Full Text] [Related]
8. Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles.
Soares S; Fonte P; Costa A; Andrade J; Seabra V; Ferreira D; Reis S; Sarmento B
Int J Pharm; 2013 Nov; 456(2):370-81. PubMed ID: 24036086
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells.
del Pozo-Rodríguez A; Delgado D; Solinís MA; Gascón AR; Pedraz JL
Int J Pharm; 2008 Aug; 360(1-2):177-83. PubMed ID: 18508211
[TBL] [Abstract][Full Text] [Related]
10. Effect of sugars on storage stability of lyophilized liposome/DNA complexes with high transfection efficiency.
Maitani Y; Aso Y; Yamada A; Yoshioka S
Int J Pharm; 2008 May; 356(1-2):69-75. PubMed ID: 18249511
[TBL] [Abstract][Full Text] [Related]
11. Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability--A step closer from promising technology to application.
Kasper JC; Schaffert D; Ogris M; Wagner E; Friess W
J Control Release; 2011 May; 151(3):246-55. PubMed ID: 21223985
[TBL] [Abstract][Full Text] [Related]
12. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
Anhorn MG; Mahler HC; Langer K
Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
[TBL] [Abstract][Full Text] [Related]
13. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid.
Vighi E; Ruozi B; Montanari M; Battini R; Leo E
Eur J Pharm Biopharm; 2007 Sep; 67(2):320-8. PubMed ID: 17368876
[TBL] [Abstract][Full Text] [Related]
14. Survival of Brucella abortus strain RB51 lyophilized and as liquid vaccine under different storage conditions.
Capsel RL; Olsen SC; Cheville NF; Thoen CO
Biologicals; 2000 Dec; 28(4):209-15. PubMed ID: 11237356
[TBL] [Abstract][Full Text] [Related]
15. A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors.
del Pozo-Rodríguez A; Pujals S; Delgado D; Solinís MA; Gascón AR; Giralt E; Pedraz JL
J Control Release; 2009 Jan; 133(1):52-9. PubMed ID: 18854203
[TBL] [Abstract][Full Text] [Related]
16. Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency.
Gao Y; Xu Z; Chen S; Gu W; Chen L; Li Y
Int J Pharm; 2008 Jul; 359(1-2):241-6. PubMed ID: 18479851
[TBL] [Abstract][Full Text] [Related]
17. A systematic study on lyophilization process of polymersomes for long-term storage using doxorubicin-loaded (PEG)₃-PLA nanopolymersomes.
Ayen WY; Kumar N
Eur J Pharm Sci; 2012 Aug; 46(5):405-14. PubMed ID: 22465658
[TBL] [Abstract][Full Text] [Related]
18. Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery.
Yu W; Liu C; Ye J; Zou W; Zhang N; Xu W
Nanotechnology; 2009 May; 20(21):215102. PubMed ID: 19423923
[TBL] [Abstract][Full Text] [Related]
19. Investigation on formulation and preparation of adenovirus encoding human endostatin lyophilized powders.
Chen S; Guo D; Guo B; Liu J; Shen Y; Xu X; Huang W; Guo S
Int J Pharm; 2012 May; 427(2):145-52. PubMed ID: 22234038
[TBL] [Abstract][Full Text] [Related]
20. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
Attama AA; Müller-Goymann CC
Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
